Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transgender Persons | 19 | 2024 | 132 | 7.220 |
Why?
|
| Transsexualism | 13 | 2023 | 37 | 5.760 |
Why?
|
| Surgeons | 6 | 2024 | 298 | 2.150 |
Why?
|
| Face | 4 | 2023 | 115 | 1.640 |
Why?
|
| Penis | 4 | 2021 | 65 | 1.280 |
Why?
|
| Feminization | 2 | 2019 | 2 | 1.210 |
Why?
|
| Surgery, Plastic | 5 | 2023 | 43 | 1.100 |
Why?
|
| Postoperative Complications | 5 | 2024 | 2592 | 1.070 |
Why?
|
| Gender Dysphoria | 3 | 2022 | 10 | 1.060 |
Why?
|
| Breast Neoplasms | 4 | 2023 | 3157 | 0.920 |
Why?
|
| Male | 36 | 2024 | 45865 | 0.880 |
Why?
|
| Female | 39 | 2024 | 50031 | 0.880 |
Why?
|
| Breast Implantation | 1 | 2024 | 15 | 0.840 |
Why?
|
| Breast Implants | 1 | 2024 | 28 | 0.830 |
Why?
|
| Cheek | 2 | 2023 | 21 | 0.800 |
Why?
|
| Patient Satisfaction | 5 | 2022 | 514 | 0.780 |
Why?
|
| Health Services Accessibility | 3 | 2024 | 491 | 0.760 |
Why?
|
| Surgical Flaps | 3 | 2021 | 259 | 0.750 |
Why?
|
| Carcinoma in Situ | 1 | 2022 | 53 | 0.750 |
Why?
|
| Humans | 55 | 2024 | 96109 | 0.740 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 126 | 0.720 |
Why?
|
| Precancerous Conditions | 1 | 2022 | 206 | 0.690 |
Why?
|
| Hormones | 1 | 2021 | 144 | 0.660 |
Why?
|
| Venous Thromboembolism | 2 | 2021 | 171 | 0.650 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 66 | 0.640 |
Why?
|
| Mastectomy | 4 | 2023 | 270 | 0.630 |
Why?
|
| Insurance Coverage | 1 | 2021 | 144 | 0.610 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2018 | 18 | 0.560 |
Why?
|
| Telemedicine | 1 | 2021 | 229 | 0.540 |
Why?
|
| Nipples | 1 | 2015 | 38 | 0.440 |
Why?
|
| Education, Medical | 1 | 2017 | 252 | 0.420 |
Why?
|
| Quality of Life | 2 | 2023 | 1816 | 0.400 |
Why?
|
| Peer Review | 2 | 2022 | 24 | 0.360 |
Why?
|
| Internship and Residency | 2 | 2023 | 1134 | 0.360 |
Why?
|
| Gender Identity | 2 | 2023 | 60 | 0.360 |
Why?
|
| Genitalia | 2 | 2022 | 20 | 0.350 |
Why?
|
| Prostheses and Implants | 3 | 2023 | 132 | 0.340 |
Why?
|
| Wound Healing | 2 | 2023 | 378 | 0.330 |
Why?
|
| Phenylephrine | 1 | 2010 | 36 | 0.320 |
Why?
|
| Drug Labeling | 1 | 2010 | 42 | 0.310 |
Why?
|
| Emotions | 2 | 2023 | 377 | 0.310 |
Why?
|
| Medication Errors | 1 | 2010 | 38 | 0.310 |
Why?
|
| Vagina | 2 | 2021 | 181 | 0.310 |
Why?
|
| Rhinoplasty | 1 | 2010 | 34 | 0.310 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 68 | 0.310 |
Why?
|
| Patient-Centered Care | 2 | 2022 | 228 | 0.300 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2022 | 286 | 0.300 |
Why?
|
| Urethra | 2 | 2020 | 115 | 0.280 |
Why?
|
| Maxillary Sinus | 1 | 2008 | 22 | 0.280 |
Why?
|
| Mucormycosis | 1 | 2008 | 18 | 0.270 |
Why?
|
| Mental Health | 3 | 2023 | 202 | 0.260 |
Why?
|
| Skull | 2 | 2019 | 273 | 0.260 |
Why?
|
| Fibromatosis, Gingival | 1 | 2006 | 1 | 0.260 |
Why?
|
| United States | 8 | 2024 | 7768 | 0.220 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2024 | 61 | 0.220 |
Why?
|
| Acellular Dermis | 1 | 2023 | 7 | 0.210 |
Why?
|
| Facial Bones | 1 | 2023 | 39 | 0.200 |
Why?
|
| Vocal Cords | 1 | 2023 | 27 | 0.200 |
Why?
|
| Patient Outcome Assessment | 1 | 2023 | 87 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3639 | 0.190 |
Why?
|
| Hyperplasia | 1 | 2022 | 149 | 0.190 |
Why?
|
| Mammaplasty | 1 | 2024 | 124 | 0.180 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 491 | 0.180 |
Why?
|
| Endoscopy | 2 | 2023 | 374 | 0.180 |
Why?
|
| Voice | 1 | 2022 | 20 | 0.180 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 20 | 0.180 |
Why?
|
| Physician Incentive Plans | 1 | 2021 | 20 | 0.180 |
Why?
|
| Reimbursement, Incentive | 1 | 2021 | 39 | 0.180 |
Why?
|
| Fee-for-Service Plans | 1 | 2021 | 31 | 0.180 |
Why?
|
| Medicare | 2 | 2024 | 458 | 0.170 |
Why?
|
| San Francisco | 1 | 2021 | 26 | 0.170 |
Why?
|
| Perioperative Period | 1 | 2021 | 29 | 0.170 |
Why?
|
| Peritoneum | 1 | 2021 | 56 | 0.170 |
Why?
|
| Infertility, Female | 1 | 2021 | 101 | 0.170 |
Why?
|
| Health Personnel | 1 | 2023 | 241 | 0.160 |
Why?
|
| Clitoris | 1 | 2020 | 4 | 0.160 |
Why?
|
| Estrogens | 1 | 2021 | 203 | 0.160 |
Why?
|
| Skin Transplantation | 1 | 2021 | 193 | 0.150 |
Why?
|
| Dermal Fillers | 1 | 2019 | 4 | 0.150 |
Why?
|
| Cephalometry | 1 | 2019 | 49 | 0.150 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2021 | 164 | 0.150 |
Why?
|
| Rhytidoplasty | 1 | 2019 | 12 | 0.150 |
Why?
|
| Penile Implantation | 1 | 2019 | 14 | 0.150 |
Why?
|
| Penile Prosthesis | 1 | 2019 | 25 | 0.150 |
Why?
|
| Ambulatory Surgical Procedures | 2 | 2009 | 82 | 0.140 |
Why?
|
| Incidence | 2 | 2021 | 1715 | 0.140 |
Why?
|
| Aging | 2 | 2023 | 766 | 0.140 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 640 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2021 | 298 | 0.140 |
Why?
|
| Medicaid | 1 | 2021 | 260 | 0.130 |
Why?
|
| Social Media | 1 | 2019 | 111 | 0.130 |
Why?
|
| Young Adult | 3 | 2024 | 7026 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2019 | 339 | 0.130 |
Why?
|
| Heart | 1 | 2019 | 591 | 0.120 |
Why?
|
| Contrast Media | 2 | 2015 | 1096 | 0.110 |
Why?
|
| Mammary Arteries | 1 | 2015 | 34 | 0.110 |
Why?
|
| Chin | 1 | 2014 | 9 | 0.110 |
Why?
|
| Wounds, Stab | 1 | 2014 | 12 | 0.110 |
Why?
|
| Graphite | 1 | 2014 | 13 | 0.110 |
Why?
|
| Societies, Medical | 2 | 2021 | 644 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1096 | 0.100 |
Why?
|
| Adult | 5 | 2024 | 28722 | 0.100 |
Why?
|
| Foreign Bodies | 1 | 2014 | 66 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2020 | 10287 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2020 | 3110 | 0.100 |
Why?
|
| Advisory Committees | 1 | 2012 | 94 | 0.090 |
Why?
|
| Middle Aged | 7 | 2024 | 28369 | 0.080 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 134 | 0.080 |
Why?
|
| Hematologic Diseases | 1 | 2009 | 79 | 0.080 |
Why?
|
| Patient Selection | 2 | 2009 | 709 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 1877 | 0.070 |
Why?
|
| Phosphatidylglycerols | 1 | 2008 | 5 | 0.070 |
Why?
|
| Amphotericin B | 1 | 2008 | 37 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2021 | 9175 | 0.070 |
Why?
|
| Phosphatidylcholines | 1 | 2008 | 53 | 0.070 |
Why?
|
| Evidence-Based Medicine | 3 | 2021 | 458 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2008 | 214 | 0.070 |
Why?
|
| Infliximab | 1 | 2008 | 163 | 0.070 |
Why?
|
| Antifungal Agents | 1 | 2008 | 126 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2008 | 175 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 187 | 0.060 |
Why?
|
| Pedigree | 1 | 2006 | 982 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2012 | 2480 | 0.050 |
Why?
|
| Aged | 4 | 2024 | 20968 | 0.050 |
Why?
|
| Thyroid Cartilage | 1 | 2023 | 1 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2003 | 41 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 136 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2002 | 83 | 0.050 |
Why?
|
| Portal Vein | 1 | 2002 | 122 | 0.050 |
Why?
|
| Strategic Planning | 1 | 2021 | 2 | 0.050 |
Why?
|
| Hepatic Artery | 1 | 2002 | 84 | 0.050 |
Why?
|
| Efficiency | 1 | 2021 | 41 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 1429 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 145 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 273 | 0.040 |
Why?
|
| Consensus | 1 | 2023 | 370 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2021 | 192 | 0.040 |
Why?
|
| Forecasting | 1 | 2021 | 317 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2021 | 327 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2021 | 168 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 228 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 483 | 0.040 |
Why?
|
| Nutritional Requirements | 1 | 1999 | 17 | 0.040 |
Why?
|
| Thrombosis | 1 | 2002 | 326 | 0.040 |
Why?
|
| Penile Erection | 1 | 2019 | 22 | 0.040 |
Why?
|
| Safety | 2 | 2009 | 147 | 0.040 |
Why?
|
| Free Tissue Flaps | 1 | 2019 | 55 | 0.040 |
Why?
|
| Curriculum | 1 | 2023 | 615 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 475 | 0.030 |
Why?
|
| Burns | 1 | 1999 | 150 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2023 | 854 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 1999 | 312 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 484 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2002 | 1201 | 0.030 |
Why?
|
| Facial Injuries | 1 | 2014 | 26 | 0.030 |
Why?
|
| Lacerations | 1 | 2014 | 30 | 0.030 |
Why?
|
| Adolescent | 2 | 2024 | 9896 | 0.030 |
Why?
|
| Skin | 1 | 2014 | 605 | 0.020 |
Why?
|
| Child | 2 | 2014 | 7626 | 0.020 |
Why?
|
| Intermittent Claudication | 1 | 1987 | 22 | 0.020 |
Why?
|
| Microspheres | 1 | 2003 | 105 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 2003 | 72 | 0.010 |
Why?
|
| Albumins | 1 | 2003 | 135 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 201 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 197 | 0.010 |
Why?
|
| Dogs | 1 | 2003 | 719 | 0.010 |
Why?
|
| Tuberculosis, Hepatic | 1 | 1981 | 2 | 0.010 |
Why?
|
| Anthropometry | 1 | 1999 | 78 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1999 | 82 | 0.010 |
Why?
|
| Animals | 2 | 2012 | 28891 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 3363 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 3974 | 0.010 |
Why?
|
| Neoplasms | 1 | 1987 | 3248 | 0.010 |
Why?
|
| Digestive System Neoplasms | 1 | 1987 | 22 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1987 | 775 | 0.000 |
Why?
|
| Angiography | 1 | 1981 | 209 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1987 | 1215 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1981 | 426 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1981 | 1619 | 0.000 |
Why?
|
| Liver | 1 | 1981 | 1238 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1981 | 793 | 0.000 |
Why?
|